Results 111 to 120 of about 1,165 (128)

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Nature Reviews Drug Discovery, 2010
Jamie Toombs, John Hardy, Stefan Teipel   +2 more
exaly  

Drug repositioning for Alzheimer's disease

Nature Reviews Drug Discovery, 2012
Amritpal Mudher, James Pickett, Paul Edison   +2 more
exaly  

Alzheimer's disease: strategies for disease modification

Nature Reviews Drug Discovery, 2010
Martin Citron, Citron Martin
exaly  

Alzheimer's Disease

New England Journal of Medicine, 2010
Frank Laferla, Henry W Querfurth, Laferla Frank M   +2 more
exaly  

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

New England Journal of Medicine, 2012
John Ringman, William E Klunk, Richard Mayeux   +2 more
exaly  

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease

Nature Reviews Drug Discovery, 2013
Harald Hampel, Hampel Harald, Vellas Bruno   +2 more
exaly  

A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease

Cell, 2017
Marco Colonna, Kuti Baruch, Hadas Keren-Shaul   +2 more
exaly  

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Nature, 2012
Jasvinder Atwal, Patrick Sulem, Robert Graham   +2 more
exaly  

Alzheimer's disease

Nature Reviews Disease Primers, 2015
Jeffrey Cummings, KAJ Blennow, Randall Bateman   +2 more
exaly  

Alzheimer's Disease

New England Journal of Medicine, 2004
Jeffrey Cummings, Cummings Jeffrey L
exaly